These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16522549)

  • 1. Neurofibromatosis type I and smoldering multiple myeloma: a case report.
    Danilatou V; Liapi D; Psyllaki M; Chatzivasili A; Chronaki I; Heliakis P
    Hematology; 2006 Feb; 11(1):45-8. PubMed ID: 16522549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent low-energy femoral shaft fractures and osteonecrosis of the jaw in a case of multiple myeloma treated with bisphosphonates.
    Grasko JM; Herrmann RP; Vasikaran SD
    J Oral Maxillofac Surg; 2009 Mar; 67(3):645-9. PubMed ID: 19231794
    [No Abstract]   [Full Text] [Related]  

  • 3. Study finds no link between bone drugs and unusual thigh fractures.
    Harv Womens Health Watch; 2010 Jul; 17(11):6. PubMed ID: 20684079
    [No Abstract]   [Full Text] [Related]  

  • 4. Bisphosphonates and atypical femoral fractures: a time for reflection.
    Compston JE
    Maturitas; 2010 Jan; 65(1):3-4. PubMed ID: 19932574
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of femoral diaphyseal fracture after long-term treatment with zoledronic acid.
    Ishizuna K; Ota D; Fukuuchi A; Teraoka M; Fujii A; Mori M; Nishi T
    Breast Cancer; 2015 Jan; 22(1):90-4. PubMed ID: 22009549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menopause practitioner perspective on the American Society of Bone and Mineral Research Task Force report on atypical femoral fracture.
    Ettinger B; Stuenkel CA; Schnatz PF
    Menopause; 2013 Oct; 20(10):1092-7. PubMed ID: 24048261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What to make of the new warning on bisphosphonates. Officials acknowledge a connection between the most popular bone drugs and rare thigh fractures.
    Harv Womens Health Watch; 2010 Dec; 18(4):6-7. PubMed ID: 21268797
    [No Abstract]   [Full Text] [Related]  

  • 8. [What do we know about atypical fractures in patients on biphosphonates treatment? A literature review using a case series].
    Méndez-Gil A; Prat-Fabregat S; Domingo-Trepat A; Navarro-López M; Camacho-Carrasco P; Carreño-Delgado A; Zumbado-Dijeres JA; García-Elvira R; Ríos-Martín M; García-Tarriño R; Ares-Rodríguez O; Ballesteros-Betancourt JR; Suso-Vergara S
    Rev Esp Cir Ortop Traumatol; 2013; 57(2):95-105. PubMed ID: 23608208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Isotypic characterization of IgA paraproteins: association with other clinical and analytic data].
    González González JB; García Delgado R; Cámara Sáez E; Ortiz Maslloréns F
    Rev Clin Esp; 1996 Aug; 196(8):529-35. PubMed ID: 8984539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates: a potential threat to your patients.
    Dreiman BB
    J Indiana Dent Assoc; 2005-2006 Winter; 84(4):4-9. PubMed ID: 16605211
    [No Abstract]   [Full Text] [Related]  

  • 11. A multicenter, randomized clinical trial comparing zoledronic acid versus observation in patients with asymptomatic myeloma.
    Musto P; Petrucci MT; Bringhen S; Guglielmelli T; Caravita T; Bongarzoni V; Andriani A; D'Arena G; Balleari E; Pietrantuono G; Boccadoro M; Palumbo A;
    Cancer; 2008 Oct; 113(7):1588-95. PubMed ID: 18683218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In brief: duration of use of bisphosphonates.
    Med Lett Drugs Ther; 2011 Oct; 53(1374):77. PubMed ID: 21959355
    [No Abstract]   [Full Text] [Related]  

  • 13. Can bisphosphonates improve outcomes in patients with newly diagnosed multiple myeloma?
    Morgan GJ
    Crit Rev Oncol Hematol; 2011 Feb; 77 Suppl 1():S24-30. PubMed ID: 21353177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequence of therapy discontinuation in bisphosphonate-associated osteonecrosis of the jaws.
    Gallego L; Junquera L
    Br J Oral Maxillofac Surg; 2009 Jan; 47(1):67-8. PubMed ID: 18639371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rare case of a bisphosphonate-related femoral diaphyseal fracture occurring below a previously fixed compression hip screw (CHS) plate.
    Cho HJ; Suh KT
    J Orthop Sci; 2015 May; 20(3):559-62. PubMed ID: 24379016
    [No Abstract]   [Full Text] [Related]  

  • 16. Going on a drug holiday?
    Bonnick SL
    J Clin Densitom; 2011; 14(4):377-83. PubMed ID: 22051091
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk factors for renal impairment in patients with solid tumors or multiple myeloma treated with zoledronic acid.
    Cha YJ; Lee YJ
    Int J Clin Pharmacol Ther; 2013 Apr; 51(4):274-82. PubMed ID: 23357846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.
    Ruggiero SL; Fantasia J; Carlson E
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):433-41. PubMed ID: 16997108
    [No Abstract]   [Full Text] [Related]  

  • 19. Bisphosphonate-related atypical femoral fracture with bone metastasis of breast cancer: case report and review.
    Hayashi K; Aono M; Shintani K; Kazuki K
    Anticancer Res; 2014 Mar; 34(3):1245-9. PubMed ID: 24596367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature.
    Siragusa S; Morice W; Gertz MA; Kyle RA; Greipp PR; Lust JA; Witzig TE; Lacy MQ; Zeldenrust SR; Rajkumar SV; Russell SJ; Hayman SR; Buadi F; Kumar SK; Dingli D; Dispenzieri A
    Ann Hematol; 2011 Jan; 90(1):101-6. PubMed ID: 20645101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.